Viewing Study NCT00303927


Ignite Creation Date: 2025-12-25 @ 5:08 AM
Ignite Modification Date: 2026-03-04 @ 9:13 AM
Study NCT ID: NCT00303927
Status: COMPLETED
Last Update Posted: 2010-03-19
First Post: 2006-03-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Capecitabine as Second-Line Therapy in Treating Patients With Stage IV Pancreatic Cancer Who Have the Thymidylate Synthase Gene
Sponsor:
Organization: